Core outcomes set for trials in people with coronavirus disease 2019
Author
dc.contributor.author
Tong, Allison
Author
dc.contributor.author
Elliott, Julián H.
Author
dc.contributor.author
Azevedo, Luciano César
Author
dc.contributor.author
Baumgart, Amanda
Author
dc.contributor.author
Bersten, Andrew
Author
dc.contributor.author
Cervantes, Lilia
Author
dc.contributor.author
Chew, Derek P.
Author
dc.contributor.author
Cho, Yeoungjee
Author
dc.contributor.author
Cooper, Tess
Author
dc.contributor.author
Crowe, Sally
Author
dc.contributor.author
Douglas, Ivor S.
Author
dc.contributor.author
Evangelidis, Nicole
Author
dc.contributor.author
Flemyng, Ella
Author
dc.contributor.author
Hannan, Elyssa
Author
dc.contributor.author
Horby, Peter
Author
dc.contributor.author
Howel, Martin
Author
dc.contributor.author
Lee, Jaehee
Author
dc.contributor.author
Liu, Emma
Author
dc.contributor.author
Lorca, Eduardo
Author
dc.contributor.author
Lynch, Deena
Author
dc.contributor.author
Marshall, John C.
Author
dc.contributor.author
Matus González, Andrea
Author
dc.contributor.author
McKenzie, Anne
Author
dc.contributor.author
Manera, Karine E.
Author
dc.contributor.author
McLeod, Charlie
Author
dc.contributor.author
Mehta, Sangeeta
Author
dc.contributor.author
Mer, Mervyn
Author
dc.contributor.author
Morris, Andrew Conway
Author
dc.contributor.author
Nseir, Saad
Author
dc.contributor.author
Povoa, Pedro
Author
dc.contributor.author
Reid, Mark
Author
dc.contributor.author
Sakr, Yasser
Author
dc.contributor.author
Shen, Ning
Author
dc.contributor.author
Smyth, Alan R.
Author
dc.contributor.author
Snelling, Tom
Author
dc.contributor.author
Strippoli, Giovanni F. M.
Author
dc.contributor.author
Teixeira Pinto, Armando
Author
dc.contributor.author
Torres, Antoni
Author
dc.contributor.author
Turner, Tari
Author
dc.contributor.author
Viecelli, Andrea K.
Author
dc.contributor.author
Webb, Steve
Author
dc.contributor.author
Williamson, Paula R.
Author
dc.contributor.author
Woc-Colburn, Laila
Author
dc.contributor.author
Zhang, Junhua
Author
dc.contributor.author
Craig, Jonathan C.
Admission date
dc.date.accessioned
2021-01-18T21:32:44Z
Available date
dc.date.available
2021-01-18T21:32:44Z
Publication date
dc.date.issued
2020
Cita de ítem
dc.identifier.citation
Critical Care Medicine (2020) 48: 11
es_ES
Identifier
dc.identifier.other
10.1097/CCM.0000000000004585
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/178264
Abstract
dc.description.abstract
Objectives: The outcomes reported in trials in coronavirus disease 2019 are extremely heterogeneous and of uncertain patient relevance, limiting their applicability for clinical decision-making. The aim of this workshop was to establish a core outcomes set for trials in people with suspected or confirmed coronavirus disease 2019. Design: Four international online multistakeholder consensus workshops were convened to discuss proposed core outcomes for trials in people with suspected or confirmed coronavirus disease 2019, informed by a survey involving 9,289 respondents from 111 countries. The transcripts were analyzed thematically. The workshop recommendations were used to finalize the core outcomes set. Setting: International. Subjects: Adults 18 years old and over with confirmed or suspected coronavirus disease 2019, their family members, members of the general public and health professionals (including clinicians, policy makers, regulators, funders, researchers). Interventions: None. Measurements: None. Main Results: Six themes were identified. "Responding to the critical and acute health crisis" reflected the immediate focus on saving lives and preventing life-threatening complications that underpinned the high prioritization of mortality, respiratory failure, and multiple organ failure. "Capturing different settings of care" highlighted the need to minimize the burden on hospitals and to acknowledge outcomes in community settings. "Encompassing the full trajectory and severity of disease" was addressing longer term impacts and the full spectrum of illness (e.g. shortness of breath and recovery). "Distinguishing overlap, correlation and collinearity" meant recognizing that symptoms such as shortness of breath had distinct value and minimizing overlap (e.g. lung function and pneumonia were on the continuum toward respiratory failure). "Recognizing adverse events" refers to the potential harms of new and evolving interventions. "Being cognizant of family and psychosocial wellbeing" reflected the pervasive impacts of coronavirus disease 2019. Conclusions: Mortality, respiratory failure, multiple organ failure, shortness of breath, and recovery are critically important outcomes to be consistently reported in coronavirus disease 2019 trials.
es_ES
Patrocinador
dc.description.sponsorship
Flinders University
National Coronavirus Disease 2019 Clinical Evidence Taskforce
Australian Government
CGIAR
Victorian Department of Health and Human Services
Ian Potter Foundation
Walter Cottman Endowment Fund
Lord Mayor's Charitable Foundation